When to start vitamin D supplementation in Ontario — the September threshold

Educational journalism, not medical advice. Every claim here is checked against its cited sources by editor Timothy Bunce — a health writer, not a physician. It isn’t specific to your situation: for health decisions, talk to your own clinician. How we work →

Some links in this article are affiliate links. If you buy through one, The Beachside Reader earns a commission at no extra cost to you. It never changes which products we pick, or what we say about them. Full affiliate disclosure →

Latitude + UVB + cholecalciferol synthesis

The mechanism is straightforward. Vitamin D3 (cholecalciferol) is synthesised in the skin when UVB photons strike 7-dehydrocholesterol in the epidermis. The photon energy required falls within a narrow window of the UVB spectrum. UVA does not produce vitamin D. UVC is filtered by the atmosphere entirely. UVB itself is filtered by atmospheric ozone, and the path length through the atmosphere depends on solar zenith angle.

Michael Holick's foundational work mapped the latitude-season interaction. Holick's 2007 review in the New England Journal of Medicine (NEJM, DOI 10.1056/NEJMra070553) drew on earlier measurements by Webb and colleagues: in Boston, at about 42 degrees north, winter sunlight produced no vitamin D synthesis in skin from November through February, and in Edmonton, at about 52 degrees, the gap stretched from October through March Webb 1988. Wasaga, Barrie, Collingwood, and the GTA sit between those two latitudes, so they fall into this "vitamin D winter" band for several months each year.

The Heaney 2003 dose-response work and the 2011 Endocrine Society guideline

Holick's Holick 2007 NEJM review and Heaney 2003's extended-dosing trial (American Journal of Clinical Nutrition) established the modern dose-response relationship between oral vitamin D3 intake and serum 25-hydroxyvitamin D (25-OH-D) concentrations. The headline finding: each 100 IU of daily vitamin D3 raises serum 25-OH-D by roughly 1 to 2 nmol/L in adults, with the response varying by body weight, baseline status, and the duration of supplementation.

The Endocrine Society's 2011 clinical practice guideline (Holick 2011, Journal of Clinical Endocrinology and Metabolism) built on this with a formal treatment protocol, written for clinicians treating diagnosed deficiency. To reach a serum 25-OH-D of 75 nmol/L (30 ng/mL — the level Holick and others argued was the lower bound of repletion) from a deficient starting point, the guideline recommended 50,000 IU of vitamin D2 or D3 once weekly for 8 weeks (roughly equivalent to 6,000 IU per day), followed by maintenance dosing of 1,500 to 2,000 IU per day. The Institute of Medicine's more conservative 2011 recommendation of 600 IU per day to maintain serum levels in already-replete individuals reflects a different question: how much is needed to prevent deficiency-related bone disease at population level, not how much is needed to reach an optimal status for an individual already below the threshold. The Endocrine Society has since revised its guidance.

Ontario seasonal-deficiency patterns (Statistics Canada CHMS)

The Canadian Health Measures Survey has measured serum 25-OH-D in nationally representative samples since 2007. Statistics Canada's published cycles (CHMS Cycle 1 through Cycle 5, covering 2007 through 2017) show that a substantial minority of Canadians have serum 25-OH-D below 50 nmol/L, more so in winter, and a smaller share fall below 30 nmol/L, the level generally used to define deficiency.

Levels are generally lower in winter than in summer, and people with darker skin pigmentation, higher body weight, and older adults are more likely to run low.

The implication for someone living in Wasaga is that vitamin D levels tend to drift down through the fall and winter, which makes early fall a sensible time to ask your clinician or pharmacist whether you need a supplement, rather than waiting until a deficiency has set in.

Blood levels and testing

The Endocrine Society's 2011 clinical practice guideline (Holick et al., J Clin Endocrinol Metab) defined sufficiency as serum 25-OH-D ≥ 75 nmol/L (30 ng/mL), with insufficiency below that and deficiency below 50 nmol/L (20 ng/mL). Health Canada uses a more conservative 50 nmol/L threshold for sufficiency. The 75 nmol/L target is contested — recent meta-analyses (Bouillon et al. 2019, Endocrine Reviews) have argued the optimum may sit between 50 and 75 — but there is broad agreement that levels below 30 nmol/L are too low.

In Ontario, OHIP covers the serum 25-hydroxyvitamin D test when it is clinically indicated (for example osteoporosis, malabsorption syndromes or chronic kidney disease), not for routine screening; otherwise it can be paid for privately through a community lab. Your family physician or nurse practitioner can tell you whether testing is worthwhile in your case.

If you and your clinician decide testing is worthwhile, they can advise on timing and on whether a follow-up test is needed.

D3 vs D2 — Tripkovic 2012

The two supplemental forms of vitamin D are D2 (ergocalciferol, derived from fungi) and D3 (cholecalciferol, derived from lanolin or lichen). The Tripkovic 2012 systematic review and meta-analysis pooled 7 randomized trials using daily, weekly, or monthly dosing schedules. Pooled across all schedules, D3 raised serum 25-OH-D more effectively than D2 overall — but broken out by regimen, that advantage was statistically significant only for infrequent (weekly or monthly) bolus dosing. For daily dosing — the way most people take vitamin D — the meta-analysis found no statistically significant difference between the two forms (mean difference 4.83 nmol/L; 95% CI −0.98 to 10.64; P=0.10).

One proposed explanation is metabolic: D3 has a longer half-life in serum and is more readily converted to 25-hydroxyvitamin D in the liver, which likely explains why its edge over D2 grows with infrequent dosing even though it doesn't reliably show up at daily doses. Prescription vitamin D in Canada is sometimes dispensed as D2 (ergocalciferol) because of historical pharmaceutical practice, but the over-the-counter market is almost entirely D3.

Lichen-derived vegan D3 is now widely available and matches the lanolin-derived form in bioavailability (Itkonen et al. 2018).

Magnesium cofactor — Uwitonze 2018

Vitamin D metabolism is magnesium-dependent. The Uwitonze 2018 review in the Journal of the American Osteopathic Association summarised the evidence that magnesium is a required cofactor for both the 25-hydroxylase and 1-alpha-hydroxylase enzymes that convert dietary vitamin D into its biologically active forms.

In principle, low magnesium status could blunt the response to vitamin D, though this has not been well tested. Many Canadian adults get less magnesium from food than recommended; leafy greens, nuts, seeds, legumes and whole grains are good sources. Whether a magnesium supplement makes sense for you is a question for your clinician or pharmacist, and the adult upper limit for magnesium from supplements is 350 mg per day.

Toxicity threshold + when to test

Vitamin D toxicity is real but requires sustained intake far above typical supplement doses. The Hathcock 2007 American Journal of Clinical Nutrition review established a no-observed-adverse-effect level (NOAEL) of 10,000 IU per day in adults. The Institute of Medicine's upper limit for daily intake is 4,000 IU, which builds in a substantial safety margin.

Toxicity manifests as hypercalcaemia — elevated blood calcium causing nausea, kidney stones, and, in severe cases, soft-tissue calcification. Reported cases have mostly involved very high intakes sustained for weeks or months, often from manufacturing errors or compounding mistakes.

More is not better, and the 4,000 IU upper limit counts all sources combined. If you are considering more than that, do so only under medical supervision, with blood monitoring. People with kidney disease, sarcoidosis or other granulomatous disease, or who take medications that affect calcium or vitamin D, should talk to their clinician or pharmacist before taking any vitamin D supplement, and supplements in pregnancy are a question for your prenatal care provider.

Why early fall is the time to ask

For Wasaga and the surrounding region, the practical point is timing: by the autumn equinox, around September 21, the sun is dropping too low for much skin synthesis, and it doesn't return in earnest until spring. That makes early fall a sensible time to review your vitamin D intake with a clinician or pharmacist. Steady year-round intake may also produce more stable serum levels than a seasonal pause-and-resume pattern.

What a clinician weighs: your diet and use of fortified foods, how much time you spend outdoors, skin pigmentation, body weight, age, medications, and any measured baseline. The doses described earlier in this article are research figures; the right amount for you, if any, is an individual decision.

If a blood test shows a low level, treatment and any follow-up testing should be guided by your clinician rather than by self-directed high-dose supplementation.

Vitamin D is fat-soluble, and Mulligan and Licata (2010) reported that blood levels rose more when it was taken with the largest meal of the day.

Practical takeaways

• Above 43 degrees north, cutaneous vitamin D synthesis is negligible through the winter months.
• Blood-level targets are contested: Health Canada treats 50 nmol/L as sufficient, while the Endocrine Society's 2011 guideline argued for 75 nmol/L. Ask your clinician whether testing makes sense for you.
• Early fall, around the September equinox, is a sensible time to review your vitamin D intake with a clinician or pharmacist.
• D3 and D2 perform similarly at daily doses; D3's edge over D2 shows up mainly with infrequent (weekly or monthly) dosing. Magnesium is required for activation.
• The adult upper limit is 4,000 IU per day from all sources; go above it only under medical supervision.

Extended takeaways

The seasonal vitamin D question is one of the few areas of nutritional science where the geography of where you live shapes the answer with unusual clarity. The 43rd parallel cutoff is not folklore — it falls out of the physics of atmospheric path length and the photochemistry of cholecalciferol synthesis. A resident of Miami at 25 degrees north does not face the same supplementation calculus as a resident of Wasaga at 44.5. The advice of generic supplement marketing — "consider vitamin D" — papers over the latitude-specific reality. In Ontario, winter vitamin D intake deserves deliberate attention: food, fortified products and, where a clinician advises it, a supplement.

The dose-response work from Holick, Heaney, and the subsequent generation of researchers has produced unusual clarity for a nutrient question. The relationship between oral D3 intake and serum 25-OH-D is reasonably predictable within the usual range, and the half-life is well-characterised. The friction is practical: despite decades of public-health messaging, the CHMS results make clear that a meaningful fraction of Canadians still enter winter with low levels.

Vitamin D's role in immune function, mood, athletic performance, and chronic disease risk has been the subject of intense and frequently overheated debate over the past 15 years. The strongest, most consistent evidence supports its role in bone health and the prevention of osteomalacia and rickets — outcomes that are difficult to ignore once they occur. Claims about cancer prevention, cardiovascular protection, and infection resistance have been less consistent, though the VITAL trial findings (Manson 2019) suggest modest benefit in some subgroups. The conservative reading of the evidence: maintain adequate status through food, fortified products and, where your clinician advises it, a supplement, and do not expect vitamin D to be a panacea.

Frequently asked questions

Do I still need to supplement if I take a multivitamin?

Many multivitamins contain some vitamin D. Check the label: the adult upper limit of 4,000 IU per day counts all sources combined. Whether you need a separate D3 on top is a question for your clinician or pharmacist.

Is vitamin D from food enough?

Often not in winter. Fatty fish (salmon, sardines, mackerel) and fortified milk are the dominant dietary sources, and many Canadians' diets fall short of the recommended intake from food alone. A dietitian, pharmacist or clinician can help you judge whether you need a supplement.

What about tanning beds?

Tanning beds are not a safe way to get vitamin D. They emit mostly UVA, which does not drive vitamin D synthesis, and indoor tanning raises melanoma risk. Health Canada advises against using tanning equipment; food, fortified products and, where your clinician advises it, a supplement are the safer routes.

Should kids supplement too?

Health Canada recommends a daily 400 IU vitamin D supplement for breastfed and partially breastfed infants, and the recommended intake for children and teens aged 1 to 18 is 600 IU per day from all sources. Children have lower upper limits than adults, so ask your child's doctor, nurse practitioner or pharmacist before giving any additional supplement.

Can I take a weekly mega-dose instead of daily?

Daily dosing is generally preferred for vitamin D specifically. A large randomized trial testing a single annual 500,000 IU oral dose in older women (not a monthly schedule) found the bolus increased fall risk by 15 percent (rate ratio 1.15) and fracture risk by 26 percent (rate ratio 1.26) versus placebo, with the excess risk concentrated in the first three months after each dose (Sanders 2010). That result doesn't establish that all infrequent-dosing schedules carry the same risk, but it's a reason to favour daily or weekly regimens over large, infrequent boluses. Any schedule other than daily is worth discussing with your clinician or pharmacist.

References